Humana Inc. (NYSE:HUM) Receives Average Rating of “Hold” from Analysts

Humana Inc. (NYSE:HUM) has been assigned a consensus rating of “Hold” from the nineteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $424.50.

A number of research analysts recently weighed in on the company. Mizuho cut their price objective on Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, January 26th. Jefferies Financial Group cut their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Barclays dropped their price objective on Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. TD Cowen dropped their price target on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Finally, Truist Financial reaffirmed a “hold” rating and set a $550.00 target price on shares of Humana in a research report on Friday, January 19th.

Humana Stock Down 0.9 %

Shares of Humana stock opened at $303.15 on Tuesday. The firm has a market cap of $36.53 billion, a price-to-earnings ratio of 18.88, a P/E/G ratio of 1.79 and a beta of 0.45. The stock has a 50-day simple moving average of $326.86 and a 200-day simple moving average of $393.28. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. Humana has a 52-week low of $299.23 and a 52-week high of $541.21.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. Humana’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the firm earned $9.38 EPS. On average, equities research analysts expect that Humana will post 16.08 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.17%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is presently 22.04%.

Insider Activity at Humana

In other news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were purchased at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now owns 2,578 shares of the company’s stock, valued at $946,358.02. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.32% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Humana

A number of institutional investors and hedge funds have recently modified their holdings of HUM. Norges Bank bought a new stake in shares of Humana during the 4th quarter valued at $676,800,000. Sanders Capital LLC bought a new stake in Humana in the fourth quarter valued at about $489,300,000. Putnam Investments LLC lifted its stake in Humana by 550.3% in the fourth quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock valued at $400,808,000 after buying an additional 740,858 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in Humana by 255.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock worth $215,241,000 after buying an additional 446,124 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of Humana by 35.9% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,523,835 shares of the insurance provider’s stock worth $741,409,000 after buying an additional 402,559 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.